FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W111189903> ?p ?o ?g. }

• W111189903 endingPage "1579" @default.
• W111189903 startingPage "1572" @default.
• W111189903 abstract "Leukemia relapse is a major cause of treatment failure for patients with acute leukemia given allogeneic bone marrow transplantation (BMT). This study evaluated whether a reduction of the dosage of cyclosporine-A (Cs-A) used for graft versus host disease (GVHD) prophylaxis could reduce relapse rate (RR) in children with acute leukemia given BMT. Fifty-nine children who had transplantation from HLA-identical siblings were randomized to receive Cs-A intravenously at a dosage of 1 mg/kg/d (Cs-A1) or of 3 mg/kg/d (Cs-A3) until patients were able to tolerate oral intake. Subsequently, both groups received Cs-A orally at a dosage of 6 mg/kg/d, with discontinuation 5 months after BMT. The probability of developing grade II-IV acute GVHD was 57% for the Cs-A1 group versus 38% for the Cs-A3 group (P = .06); the probability of developing chronic GVHD was 30% for the Cs-A1 group and 26% for the Cs-A3 group (P = NS). Three patients died of grade IV acute GVHD: 2 were in the Cs-A1 and the third in the Cs-A3 group. The RR was 15% for the Cs-A1 group and 41% for the Cs-A3 group (P = .034); 1-year transplant-related mortality estimates were 17% and 7%, respectively (P = NS). With a median observation time of 44 months from BMT, the 5-year event-free survival for children belonging to Cs-A1 and Cs-A3 groups was 70% and 51%, respectively (P = .15). Our data demonstrate that the use of low Cs-A doses is associated with a statistically significant reduction of leukemia relapse, probably due to an increased graft versus leukemia effect." @default.
• W111189903 created "2016-06-24" @default.
• W111189903 creator A5022712318 @default.
• W111189903 creator A5027372921 @default.
• W111189903 creator A5030187982 @default.
• W111189903 creator A5037248033 @default.
• W111189903 creator A5037858774 @default.
• W111189903 creator A5047447832 @default.
• W111189903 creator A5050682361 @default.
• W111189903 creator A5055854967 @default.
• W111189903 creator A5060655132 @default.
• W111189903 creator A5061275872 @default.
• W111189903 creator A5074034025 @default.
• W111189903 creator A5090000319 @default.
• W111189903 creator A5091370811 @default.
• W111189903 date "2000-03-01" @default.
• W111189903 modified "2023-09-27" @default.
• W111189903 title "Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: results of a randomized trial" @default.
• W111189903 cites W1274344746 @default.
• W111189903 cites W1530764705 @default.
• W111189903 cites W1575533059 @default.
• W111189903 cites W1599864954 @default.
• W111189903 cites W1693995824 @default.
• W111189903 cites W1809157807 @default.
• W111189903 cites W1853600164 @default.
• W111189903 cites W1954992673 @default.
• W111189903 cites W1998466067 @default.
• W111189903 cites W2000702525 @default.
• W111189903 cites W2039808932 @default.
• W111189903 cites W2053278212 @default.
• W111189903 cites W2063142731 @default.
• W111189903 cites W2067480394 @default.
• W111189903 cites W2092470944 @default.
• W111189903 cites W2123123013 @default.
• W111189903 cites W215523164 @default.
• W111189903 cites W2335857054 @default.
• W111189903 cites W2436876953 @default.
• W111189903 cites W3112391182 @default.
• W111189903 cites W4236572065 @default.
• W111189903 cites W4255119797 @default.
• W111189903 cites W4293241248 @default.
• W111189903 doi "https://doi.org/10.1182/blood.v95.5.1572.005k12_1572_1579" @default.
• W111189903 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10688810" @default.
• W111189903 hasPublicationYear "2000" @default.
• W111189903 type Work @default.
• W111189903 sameAs 111189903 @default.
• W111189903 citedByCount "151" @default.
• W111189903 countsByYear W1111899032012 @default.
• W111189903 countsByYear W1111899032013 @default.
• W111189903 countsByYear W1111899032014 @default.
• W111189903 countsByYear W1111899032015 @default.
• W111189903 countsByYear W1111899032016 @default.
• W111189903 countsByYear W1111899032017 @default.
• W111189903 countsByYear W1111899032018 @default.
• W111189903 countsByYear W1111899032019 @default.
• W111189903 countsByYear W1111899032020 @default.
• W111189903 countsByYear W1111899032021 @default.
• W111189903 countsByYear W1111899032022 @default.
• W111189903 countsByYear W1111899032023 @default.
• W111189903 crossrefType "journal-article" @default.
• W111189903 hasAuthorship W111189903A5022712318 @default.
• W111189903 hasAuthorship W111189903A5027372921 @default.
• W111189903 hasAuthorship W111189903A5030187982 @default.
• W111189903 hasAuthorship W111189903A5037248033 @default.
• W111189903 hasAuthorship W111189903A5037858774 @default.
• W111189903 hasAuthorship W111189903A5047447832 @default.
• W111189903 hasAuthorship W111189903A5050682361 @default.
• W111189903 hasAuthorship W111189903A5055854967 @default.
• W111189903 hasAuthorship W111189903A5060655132 @default.
• W111189903 hasAuthorship W111189903A5061275872 @default.
• W111189903 hasAuthorship W111189903A5074034025 @default.
• W111189903 hasAuthorship W111189903A5090000319 @default.
• W111189903 hasAuthorship W111189903A5091370811 @default.
• W111189903 hasConcept C126322002 @default.
• W111189903 hasConcept C141071460 @default.
• W111189903 hasConcept C168563851 @default.
• W111189903 hasConcept C2776863199 @default.
• W111189903 hasConcept C2778461978 @default.
• W111189903 hasConcept C2778715236 @default.
• W111189903 hasConcept C2779972918 @default.
• W111189903 hasConcept C2780007613 @default.
• W111189903 hasConcept C2911091166 @default.
• W111189903 hasConcept C71924100 @default.
• W111189903 hasConcept C90924648 @default.
• W111189903 hasConceptScore W111189903C126322002 @default.
• W111189903 hasConceptScore W111189903C141071460 @default.
• W111189903 hasConceptScore W111189903C168563851 @default.
• W111189903 hasConceptScore W111189903C2776863199 @default.
• W111189903 hasConceptScore W111189903C2778461978 @default.
• W111189903 hasConceptScore W111189903C2778715236 @default.
• W111189903 hasConceptScore W111189903C2779972918 @default.
• W111189903 hasConceptScore W111189903C2780007613 @default.
• W111189903 hasConceptScore W111189903C2911091166 @default.
• W111189903 hasConceptScore W111189903C71924100 @default.
• W111189903 hasConceptScore W111189903C90924648 @default.
• W111189903 hasIssue "5" @default.
• W111189903 hasLocation W1111899031 @default.
• W111189903 hasOpenAccess W111189903 @default.

• next